Latest News

What Modern Business Plans Need In 2026 A modern business plan in 2026 is very different from the static documents investors saw a decade ago. Today, plans need to function as working operating guides, not just fundraising brochures. That means sharper financials, clearer execution paths, and stronger evidence that the founders understand their market, their [...]

Understand the payout ratio and its significance. Learn how it helps assess dividend stocks in just one minute.

Waste Connections (TSX:WCN) shares might be the defensive dividend grower to back up the truck on after a stellar earnings showing.

Setting passive income goals is easy, but it should be realistic as to how much you can really set aside for investing.

Q2 (NYSE:QTWO) executives said artificial intelligence is creating new opportunities and risks for digital banking, with personal AI agents emerging as another channel through which consumers and businesses may interact with financial institutions. During the company’s second investor-focused AI di

Grid Dynamics (NASDAQ:GDYN) reported record third-quarter 2026 revenue and non-GAAP EBITDA, as the IT services company cited growing demand for AI-related work, higher revenue per employee and improved operating efficiency. Revenue rose 9.7% year over year and 5.7% sequentially to $114.3 million, e

Gilead Sciences (NASDAQ:GILD) reported third-quarter 2026 base business sales growth of 16% year over year, its strongest growth rate in more than a decade, as HIV products, TRODELVY and Livdelzi drove performance. The company also raised its full-year base business revenue outlook while outlining t

Exelixis (NASDAQ:EXEL) reported third-quarter 2026 revenue of approximately $659 million, supported by continued growth in its cabozantinib franchise and progress toward a potential launch of zanzalintinib in colorectal cancer. Chief Executive Officer Mike Morrissey said the company is positioning

Exponent (NASDAQ:EXPO) reported third-quarter 2026 revenue and earnings growth as demand remained strong for its engineering and scientific consulting services, particularly in user research, product safety, failure analysis and dispute-related work. Total revenue increased 18% year over year to $1

BridgeBio Pharma (NASDAQ:BBIO) reported third-quarter revenue growth driven by sales of ATTR cardiomyopathy treatment Attruby and a one-time milestone tied to European partner Bayer’s commercialization of Beyonttra. The company also outlined plans for three potential U.S. product launches over the n

Alphatec (NASDAQ:ATEC) reported third-quarter revenue growth and expanded profitability, while lowering its full-year outlook to reflect weaker biologics performance, softer thoracolumbar procedure volumes and a temporary international supply constraint. Revenue for the third quarter totaled $221 m

CareDx (NASDAQ:CDNA) reported third-quarter 2026 revenue growth of 39% as testing volumes increased, driven by its transplant business and the addition of Specialty Oncology testing following the July acquisition of Naveris. Revenue for the quarter ended Sept. 30 was $139 million, up 39% from a yea

Columbia Sportswear (NASDAQ:COLM) reported third-quarter 2026 results that exceeded its prior revenue and earnings expectations, aided by earlier-than-anticipated wholesale shipments, improved U.S. direct-to-consumer trends and continued international growth. Net sales increased 2% year over year t

Alignment Healthcare (NASDAQ:ALHC) reported third-quarter revenue growth of 37% as membership rose 31% from a year earlier, but the Medicare Advantage insurer lowered its full-year profitability outlook after elevated medical costs, provider appeals and claims-processing volatility pressured results

Amazon.com (NASDAQ:AMZN) reported third-quarter 2026 revenue of $201.9 billion, up 12% from a year earlier, while operating income rose 61% to $28.1 billion. The company’s operating margin reached a record 13.9%, according to CFO Brian Olsavsky. CEO Andy Jassy said results were led by continued acc

Net profit rose 13.1% as banking and insurance offset market volatility.

Broadcom's custom chips and Intel's foundry turnaround offer very different risks. Here's how investors could weigh the two after the recent drop.

Most of the earnings decline came from investment losses. Is the cash flow a bigger worry?

The Richards Group's monthly dividend yields 4.6%. The small-cap stock's high-margin healthcare pivot makes this passive income source an attractive pick.

For investors who want monthly passive income without owning rental properties, Crombie REIT's 5.7% yield deserves a closer look.

Capital reallocation away from soft-margin consumer loans funds both technology investments and shareholder returns.

Facility closures and price increases taking full effect in 2027 could reshape earnings power.

Micron's stock is incredibly cheap, and the market has it wrong.

Debt reduction running two quarters ahead of schedule restores financial flexibility for future growth.

Loan originations surged 23% while deposit growth accelerated, yet commercial real estate competition is trimming loan balances.